All In MedTech

Device Trial Radar · NCT02476318

A Study to Evaluate the Safety and Performance of ArterX™ Vascular Sealant in Sealing Synthetic Arterial Grafts

Last checked: Nov 19, 2026Latest source record: Jun 19, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Jun 2007

Primary completion

Aug 2007

Study completion Nov 2007

Sponsor

Lead sponsor
Tenaxis Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 19, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, multi-center study to evaluate the safety and performance outcomes of the ArterX Vascular Sealant when used for prophylactic sealing of suture lines at the anastomosis between native vessel and synthetic vascular grafts.

Conditions

  • Vascular Disease

Interventions

  • ArterX Vascular SealantDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of anastomoses with immediate sealing of the suture lineTime frame: Intraoperative

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Klinikum der Universitat zu Koln

    Cologne, Germany

  • Krankenhaus Dresden Friedrichstadt

    Dresden, Germany

  • Chirugische Uni Klinikum

    Ulm, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.